Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Warrants and options expiring
View:
Post by 2b7f6fab on Jun 07, 2024 10:35am

Warrants and options expiring

239 million shares outstanding,
  87 million warrants outstanding,  67 million warrants expire in Aug/Sep
  18 million options outstanding, 10 million expire in September
334 million fully diluted.

If anyone was planning a hostile takeover would it be smart to wait for these to expire?
The great Bencro used to say they don't do hostile takeovers in this industry.
Comment by 13X2413 on Jun 07, 2024 10:50am
I guess with 22,000 shares traded today, curing mouse cancer doesn't interest the investing public. 
Comment by Lesalpes29 on Jun 07, 2024 11:00am
This post has been removed in accordance with Community Policy
Comment by Lesalpes29 on Jun 07, 2024 11:01am
My last post is for 13Xdumdum.
Comment by tdon1229 on Jun 07, 2024 11:05am
Lesalpes29, Maybe you could take it to PM....
Comment by menoalittle on Jun 07, 2024 11:06am
Smart to wait for warrant expiration? mmmm... not necessarily.  Might depend on whether an offer would be enticing enough to result in a majority of those holding warrants to exercise them and then vote those shares in favor of the takeover.
Comment by menoalittle on Jun 07, 2024 11:12am
Obviously (or at least, what I think would be obvious), any hostile bid (if there were to be one) is not going to be stupid cheap, or no one will vote for it.  
Comment by chry200030 on Jun 07, 2024 11:23am
Yes, nothing under $10 a share... 
Comment by menoalittle on Jun 07, 2024 11:26am
LOL... nice to dream about.  But a small fraction of that would undoubtedly draw many millions of votes out of the woodwork in a proxy fight!
Comment by 2b7f6fab on Jun 07, 2024 11:35am
My comment about Bencro was tonque in cheek,  Anyways, if a party was interested in acquiring the technology for say $1 billion, then fully diluted would receive approx $3/sh or if after September $4/sh. I'm just not sure how we get out of this low share price trap.  BTD still seems months away :(
Comment by StevenBirch on Jun 07, 2024 11:50am
Why have we seen mutiple deals by big pharma that take stocks from $2-3 to $25-30, multi billion $ deals, but when it comes to TLT we are going to get bought cheap? It's way too early to put a valuation on this stock and does anyone think that Roger has painstakingly done these many small PPs just to give the company away at the first sign of interest? How do we know he hasn't had an offer ...more  
Comment by menoalittle on Jun 07, 2024 12:10pm
>> when it comes to TL we are going to get bought cheap?  A hostile takeover bid is precisely intended to do that.  And how many LONGTERM shareholder here might gladly exchange TLT shares (at a reasonably decent premium) for shares in another company that they are fully persuaded will carry them over the goal line, rather than being subjected to the never ending small ...more  
Comment by menoalittle on Jun 07, 2024 12:18pm
This is also why I said alarm bells ought to be going off in the heads (of those that have been selling shares, thinking they are quickly going to replace them with other - perhaps cheaper - shares in another pp.)  I think there's a risk here that they simply aren't paying attention to, especially with that many warrants set to expire in August.
Comment by reconsider on Jun 07, 2024 1:45pm
Unfortunately, the falling wedge in which we are for the last 2 years says there will be more chances to buy cheaper... I hope I'm wrong and we get out of it already. But this seems to me the most basic lesson of market sentiment: A week ago this chat was gloomy (and we were in the bottom of the wedge), turns out we do a +50% in 2 sessions. Now everybody is happy and talking in the dollars ...more  
Comment by Alamir1111 on Jun 07, 2024 3:07pm
Anything over 1.00$ I'm voting for it
Comment by menoalittle on Jun 07, 2024 3:22pm
As long as it's a stock exchange and not a cash offer, I have no doubt that there would be many millions of other shares that would vote likewise.  At this point, I just don't think there's all that many that have given this any thought whatsoever.
Comment by StevenBirch on Jun 07, 2024 7:30pm
You guys are jokers, $1 really? I don't think there a single real shareholder that would vote for that.
Comment by Alamir1111 on Jun 07, 2024 9:45pm
 Think looking at .19  or at 1.00 would change quite a lot of real shareholders minds
Comment by 2b7f6fab on Jun 07, 2024 11:25pm
Lots of smart players on this board imo, especially menolittle.  What a low ball TO offer does is allow warrant holders to excercise their warrants.  Theralase then has $20 million in cash to move forward. eom.
Comment by DJDawg on Jun 07, 2024 11:55am
My dream scenario is - TLT gets the 540, 630 and 720 data in the next month or two - it looks great with durable response - spikes price to over 0.35 - warrants are redeemed for 20m in cash (although dilutes stock a bit, sigh) - no more PPs for a while - fast roll on phase 1 with the cash infusion. But not likely. Sigh. Just out of curiousity, 0.35 is a break even strike price on the warrants ...more  
Comment by CAinPlap on Jun 07, 2024 12:21pm
I don't think we have another news release expected in time to get the warrants in the money in time. I think too many of those near the top of Roger's rolodex are only interested in holding the warrants and will sell out their shares to participate in the PP's Roger is forced into.  Self-fullfilling prohecy/circular reference.  I suspect we start seeing anonymous start ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250